Information

EuroPDX and PDXNet consortia publish a milestone paper on PDX reliability

12. 02. 2021 Information News Service

Woo, X.Y., Giordano, J., Srivastava, A. et al. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts. Nat Genet 53, 86–99 (2021). https://doi.org/10.1038/s41588-020-00750-6 Patient-derived xenografts (PDXs) are resected human tumors engrafted into mice for preclinical studies and therapeutic testing. It has been proposed that the mouse host affects tumor evolution during PDX engraftment and propagation, affecting…

IMPC 2020 annual highlights

Do not miss the best of IMPC work, including research publications, data updates, global collaborations in 2020, and IMPC plans for the future. https://review.mousephenotype.org/

IMPC elects a new senior leadership team

02. 02. 2021 Information News

The IMPC is pleased to announce the election of a new Senior Leadership Team. Radislav Sedláček is the new Chair of the IMPC, and Yann Herault the new Vice-Chair. Steve Brown, who was the Chair of the IMPC, has stepped down to become the Past Chair. Read the full article at the IMPC website.

Radislav Sedlacek became the chairman of IMPC

12. 01. 2021 Information News PR

Nineteen research institutions from around the world, including the Czech Republic, joined forces within the IMPC (International Mouse Phenotyping Consortium) to jointly decipher the function of all, approximately 20,000 mammalian (and human), genes. The result is an ever-growing “encyclopaedia” that helps to identify the emergence of human diseases and propose new treatments. Thanks to his…

Read our new issue of the Phenogenomics Newsletter

23. 11. 2020 Information News

The first issue of Volume 5 (2020) of the Phenogenomics Newsletter has been just released. It features overviews of the services available to researchers and current or potential collaboration partners. Its objective is to highlight recent achievements, introduce new technologies and directions for future development, and allows insights into work and life at the CCP.…

Orbis Pictus Award 2020 to Elizabeth Hillman

02. 11. 2020 Information News

The Orbis Pictus 2020 Award, sponsored by the Czech Centre for Phenogenomics, was awarded to Elizabeth M. C. Hillman, one of the most outstanding investigators in the fields of biophotonics and bioengineering. The Orbis Pictus Lecture was presented on the occasion of the 16th Transgenic Technology Meeting (TT2020). Elizabeth M.C. Hillman is a Professor of…

Nobel Prize in Chemistry 2020 – CRISPR/Cas9 genetic scissors

07. 10. 2020 Information News

The Nobel Prize in Chemistry 2020 was awarded jointly to Emmanuelle Charpentier and Jennifer A. Doudna for the development of a method for genome editing. For more information visit the Nobel Prize website. Interested in using CRISPR/Cas9 technology? Our proficient team of Transgenic and Archiving Module provides services from design to delivery of a mutant…

European Research Initiative for Pre-clinical, Environmental, Virtual Integrative Assessments, and Therapies

23. 09. 2020 Information News

The PREVALENT initiative brings together 15 partners across 9 European countries who have joined forces to implement a novel European Research Infrastructure for pre-clinical, environmental, virtual integrative assessments, and therapeutics development. PREVALENT integrates essential pre-clinical research platforms ranging from pre-clinical evaluations of drugs, disease modelling using precision animal models, medicinal chemistry, and the assessment of…

New jobs in CCP

24. 08. 2020 Information Jobs

As CCP is constantly developing we would like to inform you about our current job openings. MALDI research specialist Lung Phenotyping Module head For more details please see our Career page

CCP Phenogenomics Conference 2020 Online

04. 08. 2020 Information

Follow the conference online: https://live.biocev.org Main topics: Therapeutics, therapeutic target and preclinical evaluationEnvironmental stressors in health / Bioinformatics in gene networks and therapeutics assessment / Immunity /Genetic base of diseases

1 2 3 7